BIOSANTE PHARMACEUTICALS INC's ticker is BPAX and the CUSIP is 09065V302. A total of 34 filers reported holding BIOSANTE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $28,000 | – | 28,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 2,244,663 | $2,545,000 | 1.84% |
| Zuckerman Investment Group, LLC | 15,052 | $15,000 | 0.00% |
| Saiers Capital, LLC | 216,667 | $11,000 | 0.00% |
| LifePlan Financial Group, Inc | 5 | $0 | 0.00% |
| KNIGHT CAPITAL GROUP LLC | 13,385 | $13,000 | 0.00% |
| D.A. DAVIDSON & CO. | 166 | $0 | 0.00% |
| BLACKROCK ADVISORS LLC | 8,984 | $9,000 | 0.00% |
| UBS AG | 3,000 | $3,000 | 0.00% |
| UBS AG | 3,600 | $4,000 | 0.00% |
| UBS AG | 23,825 | $24,000 | 0.00% |